| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5298 | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1331 | 2021 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 739 | 2021 |
| Longitudinal analysis of Plasmodium sporozoite motility in the dermis reveals component of blood vessel recognition CS Hopp, K Chiou, DRT Ragheb, AM Salman, SM Khan, AJ Liu, P Sinnis Elife 4, e07789, 2015 | 139 | 2015 |
| Natural parasite exposure induces protective human anti-malarial antibodies G Triller, SW Scally, G Costa, M Pissarev, C Kreschel, A Bosch, E Marois, ... Immunity 47 (6), 1197-1209. e10, 2017 | 134 | 2017 |
| Prime and target immunization protects against liver-stage malaria in mice A Gola, D Silman, AA Walters, S Sridhar, S Uderhardt, AM Salman, ... Science translational medicine 10 (460), eaap9128, 2018 | 74 | 2018 |
| Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity” KJ Ewer, K Sierra-Davidson, AM Salman, JJ Illingworth, SJ Draper, ... Vaccine 33 (52), 7444-7451, 2015 | 74 | 2015 |
| The Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites as a candidate for preerythrocytic and transmission-blocking vaccines DA Espinosa, J Vega-Rodriguez, Y Flores-Garcia, AR Noe, C Muñoz, ... Infection and immunity 85 (2), 10.1128/iai. 00498-16, 2017 | 68 | 2017 |
| Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates RJ Longley, AM Salman, MG Cottingham, K Ewer, CJ Janse, SM Khan, ... Scientific reports 5 (1), 11820, 2015 | 64 | 2015 |
| Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models AM Salman, E Montoya-Díaz, H West, A Lall, E Atcheson, ... Scientific reports 7 (1), 46482, 2017 | 50 | 2017 |
| Generation of transgenic rodent malaria parasites expressing human malaria parasite proteins AM Salman, CM Mogollon, J Lin, FJA van Pul, CJ Janse, SM Khan Malaria Vaccines: Methods and Protocols, 257-286, 2015 | 47 | 2015 |
| Tailoring a Plasmodium vivax vaccine to enhance efficacy through a combination of a CSP virus-like particle and TRAP viral vectors E Atcheson, K Bauza, AM Salman, E Alves, J Blight, ME Viveros-Sandoval, ... Infection and immunity 86 (9), 10.1128/iai. 00114-18, 2018 | 36 | 2018 |
| The use of transgenic parasites in malaria vaccine research AS Othman, C Marin-Mogollon, AM Salman, BM Franke-Fayard, CJ Janse, ... Expert review of vaccines 16 (7), 685-697, 2017 | 36 | 2017 |
| Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6 M Ruhwald, L De Thurah, D Kuchaka, MR Zaher, AM Salman, ... Scientific reports 7 (1), 45969, 2017 | 36 | 2017 |
| A Plasmodium berghei sporozoite-based vaccination platform against human malaria AM Mendes, M Machado, N Gonçalves-Rosa, IJ Reuling, L Foquet, ... npj Vaccines 3 (1), 33, 2018 | 31 | 2018 |
| Combination of RTS, S and Pfs25-IMX313 induces a functional antibody response against malaria infection and transmission in mice F Brod, K Miura, I Taylor, Y Li, A Marini, AM Salman, AJ Spencer, CA Long, ... Frontiers in immunology 9, 422490, 2018 | 28 | 2018 |
| Evaluation of Plasmodium vivax cell-traversal protein for ookinetes and sporozoites as a preerythrocytic P. vivax vaccine E Alves, AM Salman, F Leoratti, C Lopez-Camacho, ME Viveros-Sandoval, ... Clinical and Vaccine Immunology 24 (4), e00501-16, 2017 | 25 | 2017 |
| Assessment of the Plasmodium falciparum preerythrocytic antigen UIS3 as a potential candidate for a malaria vaccine RJ Longley, BR Halbroth, AM Salman, KJ Ewer, SH Hodgson, CJ Janse, ... Infection and Immunity 85 (3), 10.1128/iai. 00641-16, 2017 | 24 | 2017 |
| Human B cells produce chemokine CXCL10 in the presence of Mycobacterium tuberculosis specific T cells ST Hoff, AM Salman, M Ruhwald, P Ravn, I Brock, N Elsheikh, ... Tuberculosis 95 (1), 40-47, 2015 | 22 | 2015 |
| Non-viral delivery of CRISPR/Cas cargo to the retina using nanoparticles: current possibilities, challenges, and limitations A Salman, A Kantor, ME McClements, G Marfany, S Trigueros, ... Pharmaceutics 14 (9), 1842, 2022 | 19 | 2022 |
